Home » Newsletters » BioWorld Asia

BioWorld Asia

May 26, 1999

View Archived Issues

TAB, Proteus Will Merge To Form #63M Company

Protein Discovery Could Lead To Oxygen-Sensing Answers

Evotec, Qiagen Form Venture For Nucleic Acid Systems

Chiroscience Finds Bone Gene With Osteoporosis Implications

BresaGens IPO Will Help Fund Work In Stem Cells

Phase II Trials Under Way For Xenovas XR9576 Drug

XTLs Trimera HBV Mouse Model Demonstrates Antiviral Efficacy

Israel Seeks European Partners

Oxford Biomedica Partners With Korean Gene Therapy Company

Biotech Salmon In The Pink

Celltech On Track To File U.S. NDA In Third Quarter

Alizyme Gets OK For Phase II On Renzapride

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld Science
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.